NINDS and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) invite grant applications for translational research in neuromuscular disease. This announcement is supported by 2 funding mechanisms: R21 and U01.
Neuromuscular diseases target the components of the motor unit—which is defined as the motoneuron, its axon, the neuromuscular junctions that it forms, and the skeletal muscle fibers that it innervates. These diseases represent a considerable clinical burden that is largely without effective therapies. Recent discoveries offer promising opportunities for treating neuromuscular diseases.
Potential applicants should contact Dr. John Porter, program director, Neurogenetics, NINDS; telephone: 301-496-5745; email: email@example.com. For more information visit http://grants.nih.gov/grants/guide/pa-files/PAR-08-228.html or http://grants.nih.gov/grants/guide/pa-files/PAR-08-229.html.